Sol-Gel Technologies Ltd. (SLGL): Price and Financial Metrics


Sol-Gel Technologies Ltd. (SLGL): $4.55

-0.12 (-2.57%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SLGL Stock Summary

  • The ratio of debt to operating expenses for SOL-GEL TECHNOLOGIES LTD is higher than it is for about just 9.56% of US stocks.
  • With a year-over-year growth in debt of -33.42%, SOL-GEL TECHNOLOGIES LTD's debt growth rate surpasses merely 9.23% of about US stocks.
  • Revenue growth over the past 12 months for SOL-GEL TECHNOLOGIES LTD comes in at 471.6%, a number that bests 97.85% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to SOL-GEL TECHNOLOGIES LTD, a group of peers worth examining would be HYLN, ERYP, IPSC, DRRX, and DBVT.
  • Visit SLGL's SEC page to see the company's official filings. To visit the company's web site, go to www.sol-gel.com.

SLGL Valuation Summary

  • SLGL's EV/EBIT ratio is 9.5; this is 25% higher than that of the median Healthcare stock.
  • Over the past 58 months, SLGL's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for SLGL.

Stock Date P/S P/B P/E EV/EBIT
SLGL 2022-11-01 3.5 2.3 12.2 9.5
SLGL 2022-10-31 3.5 2.3 12.0 9.3
SLGL 2022-10-28 3.3 2.2 11.6 8.9
SLGL 2022-10-27 3.3 2.2 11.5 8.8
SLGL 2022-10-26 3.3 2.2 11.3 8.7
SLGL 2022-10-25 3.4 2.3 11.8 9.1

SLGL Price Target

For more insight on analysts targets of SLGL, see our SLGL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $19.25 Average Broker Recommendation 1.25 (Strong Buy)

SLGL Stock Price Chart Interactive Chart >

Price chart for SLGL

SLGL Price/Volume Stats

Current price $4.55 52-week high $8.51
Prev. close $4.67 52-week low $3.94
Day low $4.35 Volume 14,200
Day high $4.90 Avg. volume 11,111
50-day MA $4.90 Dividend yield N/A
200-day MA $5.86 Market Cap 105.24M

Sol-Gel Technologies Ltd. (SLGL) Company Bio


Sol-Gel Technologies Ltd., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company’s lead product candidates include VERED that has completed Phase II clinical trials for the treatment of papulopustular rosacea; and TWIN and SIRS-T, which has completed Phase II clinical trials for the treatment of acne vulgaris. It is also involved in the development of generic dermatological candidates; and formulation and pre-clinical development of early stage product candidates for acne and rosacea, and other dermatological indications. The company was founded in 1997 and is based in Ness Ziona, Israel


SLGL Latest News Stream


Event/Time News Detail
Loading, please wait...

SLGL Latest Social Stream


Loading social stream, please wait...

View Full SLGL Social Stream

Latest SLGL News From Around the Web

Below are the latest news stories about SOL-GEL TECHNOLOGIES LTD that investors may wish to consider to help them evaluate SLGL as an investment opportunity.

Analysts Offer Insights on Healthcare Companies: Sol-Gel Technologies (SLGL), Zentalis Pharmaceuticals (ZNTL) and Oncology Institute, Inc. (TOI)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sol-Gel Technologies (SLGL – Research Report), Zentalis Pharmaceuticals (ZNTL – Research Report) and Oncology Institute, Inc. (TOI – Research Report) with bullish sentiments. Sol-Gel Technologies (SLGL) Raymond James analyst Elliot Wilbur maintained a Buy rating on Sol-Gel Technologies today and set a price target of $13.00. The company's shares closed last Friday at $4.74, close to its 52-week low of $3.94. According to TipRanks.

Christine Brown on TipRanks | November 11, 2022

Sol-Gel Technologies Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Growth trends for TWYNEO and EPSOLAY continue to improve, demonstrating robust uptake by prescribersSol-Gel’s cash runway expected to extend through the end of the first quarter of 2024 NESS ZIONA, Israel, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company focused on identifying, developing, commercializing or partnering branded and generic topical drug products for the treatment of skin diseases, announced today financial results for the third qua

Yahoo | November 10, 2022

Sol-Gel Technologies (NASDAQ:SLGL) investors are sitting on a loss of 45% if they invested a year ago

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if...

Yahoo | November 3, 2022

Sol-Gel Technologies Appoints Michael Glezin Vice President, Business Development

NESS ZIONA, Israel, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company focused on identifying, developing, commercializing or partnering branded and generic topical drug products for the treatment of skin diseases, announced today the appointment of Michael Glezin to the position of Vice President, Business Development. In this position, Mr. Glezin will be responsible for identifying new in-licensing business opportunities as well as potential comm

Yahoo | October 3, 2022

Are Strong Financial Prospects The Force That Is Driving The Momentum In Sol-Gel Technologies Ltd.'s NASDAQ:SLGL) Stock?

Sol-Gel Technologies (NASDAQ:SLGL) has had a great run on the share market with its stock up by a significant 20% over...

Yahoo | September 19, 2022

Read More 'SLGL' Stories Here

SLGL Price Returns

1-mo N/A
3-mo N/A
6-mo -20.87%
1-year -38.76%
3-year -49.28%
5-year N/A
YTD -38.51%
2021 -24.41%
2020 -42.92%
2019 184.88%
2018 N/A
2017 N/A

Continue Researching SLGL

Want to see what other sources are saying about Sol-Gel Technologies Ltd's financials and stock price? Try the links below:

Sol-Gel Technologies Ltd (SLGL) Stock Price | Nasdaq
Sol-Gel Technologies Ltd (SLGL) Stock Quote, History and News - Yahoo Finance
Sol-Gel Technologies Ltd (SLGL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7249 seconds.